Seiler R W, Greiner R H, Zimmerman A, Markwalder H
J Neurosurg. 1978 Jun;48(6):861-5. doi: 10.3171/jns.1978.48.6.0861.
Twenty consecutive patients with supratentorial Grade III and IV astrocytomas were treated with postoperative radiotherapy, and a simultaneous induction chemotherapy with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), procarbazine, bleomycin, and maintenance chemotherapy with CCNU. They were compared to 32 retrospective control patients selected similarly, who had received postoperative radiation therapy alone. The median survival time was 56 weeks for the combined treatment group, and 51 weeks for the control group. There was no statistical difference in survival in the two groups of patients.
连续20例幕上III级和IV级星形细胞瘤患者接受了术后放疗,同时采用1-(2-氯乙基)-3-环己基-1-亚硝基脲(CCNU)、丙卡巴肼、博来霉素进行诱导化疗,并采用CCNU进行维持化疗。将他们与32例同样入选的回顾性对照患者进行比较,这些对照患者仅接受了术后放疗。联合治疗组的中位生存时间为56周,对照组为51周。两组患者的生存率无统计学差异。